Your browser doesn't support javascript.
loading
PATRIOT: A phase I study to assess the tolerability, safety and biological effects of a specific ataxia telangiectasia and Rad3-related (ATR) inhibitor (AZD6738) as a single agent and in combination with palliative radiation therapy in patients with solid tumours.
Dillon, M T; Boylan, Z; Smith, D; Guevara, J; Mohammed, K; Peckitt, C; Saunders, M; Banerji, U; Clack, G; Smith, S A; Spicer, J F; Forster, M D; Harrington, K J.
Affiliation
  • Dillon MT; The Institute of Cancer Research, London, UK.
  • Boylan Z; The Royal Marsden NHS Foundation Trust, London, UK.
  • Smith D; Cancer Research UK, London, UK.
  • Guevara J; The Royal Marsden NHS Foundation Trust, London, UK.
  • Mohammed K; The Royal Marsden NHS Foundation Trust, London, UK.
  • Peckitt C; The Royal Marsden NHS Foundation Trust, London, UK.
  • Saunders M; The Royal Marsden NHS Foundation Trust, London, UK.
  • Banerji U; The Christie NHS Foundation Trust, UK.
  • Clack G; The Royal Marsden NHS Foundation Trust, London, UK.
  • Smith SA; Department of Oncology and Metabolism, University of Sheffield Medical School, Beech Hill Road, SHEFFIELD S10 2RX, UK.
  • Spicer JF; AstraZeneca, Cambridge, UK.
  • Forster MD; Kings College London, UK.
  • Harrington KJ; University College London Hospitals NHS Foundation Trust and UCL Cancer Centre, London UK.
Clin Transl Radiat Oncol ; 12: 16-20, 2018 Aug.
Article in En | MEDLINE | ID: mdl-30073210
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Clin Transl Radiat Oncol Year: 2018 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Clin Transl Radiat Oncol Year: 2018 Document type: Article Affiliation country: Country of publication: